Company intelligence / Profile preview

MVM Partners

London, United Kingdommvm.com ↗

Ownership: Private
Development stage: Commercial

Overview

MVM Partners is a leading global healthcare venture capital firm investing in innovative life science companies since 1997. It manages multiple funds totaling over $700 million AUM. The firm supports growth-stage businesses developing differentiated products or technologies across biopharma, medical devices/technology, diagnostics/tools/platforms and digital health. Its investments have led to over 40 exits including IPOs and acquisitions.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Small moleculeMonoclonal antibodyGene therapyCell therapy
Industry: Investors

Partnerships

Novo HoldingsIndex VenturesAdvent Life SciencesGilde Healthcare

Beyond the preview

Go deeper on MVM Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MVM Partners.

Explore the full profile